MeSH tree: D13.570.800
Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one step ahead. Now, researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified ...
Sep 26, 2025
0
53
Have you recently cut down on caffeine and feel like you're having the most vivid dreams of your life?
Sep 8, 2025
0
20
Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute myocardial infarction and cardiogenic ...
Sep 1, 2025
0
19
Dual antiplatelet therapy after cardiac bypass surgery is no more effective than acetylsalicylic acid alone and also increases the risk of serious bleeding. This is shown in a study by researchers at Karolinska Institutet ...
Sep 1, 2025
0
20
There was no benefit to modulating the intensity of antiplatelet therapy compared with standard antiplatelet therapy in high-risk patients who had undergone complex stenting procedures, according to late-breaking research ...
Sep 1, 2025
0
10
Most patients with high-risk myelodysplastic syndromes (MDS) do not receive guideline-recommended treatment with hypomethylating agents (HMAs), according to results published in Blood Neoplasia. The findings suggest that ...
Aug 6, 2025
0
11
Encouraging early results from a SAHMRI-led clinical trial offer new hope to people diagnosed with chronic myelomonocytic leukemia (CMML), a rare and aggressive form of blood cancer.
Jul 31, 2025
0
24
Spinal cord damage—whether from traumatic injury or conditions such as spina bifida—can have a profound impact on bladder function. This can result in neurogenic bladder, a problem in which damage to the nerves involved in ...
Jul 30, 2025
0
23
Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment—immunotherapy—may help change the environment where cancer cells live, possibly helping the ...
Jul 29, 2025
0
20
The targeted drug olutasidenib is highly effective in certain patients with myelodysplastic syndrome (MDS), a condition considered incurable without transplantation, according to a new clinical study led by researchers at ...
Jul 28, 2025
0
21
